Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arfolitixorin and Pemetrexed in Resectable Rectal Cancer
NCT01397305Phase 2Completed
- Sponsor
- Isofol Medical
- Start
- Apr 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arfolitixorin in rectal cancer, sponsored by Isofol Medical. Started Apr 2011; status: completed.
02
Drugs
arfolitixorin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01397305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01397305.